Is Pfizer's 6.9%-Yielding Dividend Still Safe?
Healthcare giant (NYSE: PFE) has been offering a high yield for some time. But that hasn't been enough to get investors to buy up the stock. You can see that in its sluggish share price, and also in the fact that the dividend still yields an incredibly high amount at 6.9%. That's nearly six times the S 500 average of 1.2%.
Investors are clearly having doubts about the dividend, and perhaps the company as well. If they weren't, then clearly it would be a steal of a deal, the stock would take off, and the yield would come down. If investors aren't touching a stock, there's usually some nagging concern about it.
Below, I'll look at whether Pfizer's dividend is safe and whether it could be a reliable income stock to own right now.
Source Fool.com
Pfizer Inc. Aktie
Die Pfizer Inc. Aktie verzeichnet mehrere Buy-Einschätzungen, was auf eine positive Stimmung hindeutet.
Die Community erwartet für Pfizer Inc. ein Kursziel von 27 €, was eine Steigerung von über 20% gegenüber 22.44 € bedeuten würde.
